News Search Results
Aug 14, 2024, 09:30 ET KHALIFA KUSH ANNOUNCES EUROPEAN EXPANSION, LAUNCHING IN GERMANY IN 2025
2025, Khalifa Kush will enter the German medical cannabis market through a strategic multi-year partnership with Berlin-based Sanity Group and its leading medical cannabis brand, avaay Medical.
More news about: Khalifa Kush
Aug 14, 2024, 08:00 ET IM Cannabis Reports Second Quarter Financial Results
Aug. 14, 2024 /CNW/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announced its financial results today for the second quarter ended June 30, 2024. All amounts are reported
More news about: IM Cannabis Corp.
Aug 14, 2024, 08:00 ET IM Cannabis Reports Second Quarter Financial Results
Aug. 14, 2024 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announced its financial results today for the second quarter ended June 30, 2024. All amounts are reported
More news about: IM Cannabis Corp.
Aug 14, 2024, 07:00 ET MediPharm Labs Reports Second Quarter Results Closing in on Positive Adjusted EBITDA(1) as Gross Profit Continues to Improve
in both spray and inhaler formats, is expected to expand the Company's product offerings in the adult use wellness, Canadian medical cannabis, and international medical cannabis markets.(2)Launch of SEDDS Capsules: In partnership with Avicanna, the company successfully manufactured
More news about: MediPharm Labs Corp.
Aug 13, 2024, 08:00 ET /R E P E A T -- MediPharm Labs Sets Date to Report Second Quarter 2024 Financial Results/
This acquisition also included Harvest Medical Clinics in Canada which provides medical cannabis patients with Physician consultations for medical cannabis education and prescriptions. The Company carries out its operations in compliance with all applicable laws
More news about: MediPharm Labs Corp.
Aug 12, 2024, 07:00 ET Aurora Cannabis Announces Results of 2024 Annual General and Special Meeting
Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, is pleased to announce the voting results from its Annual General and Special Meeting of Shareholders (the "Meeting") held
More news about: Aurora Cannabis Inc.
Aug 09, 2024, 07:15 ET Canopy Growth Reports First Quarter Fiscal Year 2025 Financial Results
decrease of 6% year-over-year, with record Canada medical cannabis net revenue offset by lower adult-use cannabis net revenues. Canada medical cannabis net revenue increased 20% year-over-year, driven in part by strong demand for high-margin
More news about: Canopy Growth Corporation
Aug 08, 2024, 16:30 ET MediPharm Labs Sets Date to Report Second Quarter 2024 Financial Results
This acquisition also included Harvest Medical Clinics in Canada which provides medical cannabis patients with Physician consultations for medical cannabis education and prescriptions. The Company carries out its operations in compliance with all applicable laws
More news about: MediPharm Labs Corp.
Aug 07, 2024, 16:02 ET Curaleaf Announces CEO Transition
late-stage cancer patients use medical grade cannabis. Under Boris Jordan's leadership, the Company pivoted into medical cannabis dispensaries and opened its first location in New Jersey in 2015, remaining dedicated to supporting medical patients
More news about: Curaleaf Holdings, Inc.
Aug 07, 2024, 07:00 ET Aurora Cannabis Announces Fiscal 2025 First Quarter Results and Delivers Positive Free Cash Flow
million in Q1 2025 vs $32.6 million in the prior year quarter, an increase of 10%. Medical Cannabis:Medical cannabis net revenue1 was $47.2 million, a 13% increase from the prior year quarter, delivering
More news about: Aurora Cannabis Inc.
Aug 06, 2024, 08:30 ET IM Cannabis to Report Second Quarter 2024 Financial Results on Wednesday, August 14th at 9:00am ET
2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial
More news about: IM Cannabis Corp.
Aug 06, 2024, 08:30 ET IM Cannabis to Report Second Quarter 2024 Financial Results on Wednesday, August 14th at 9:00am ET
2024 /CNW/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial
More news about: IM Cannabis Corp.
Aug 06, 2024, 07:15 ET Ascend Wellness Expands Access to Non-Medical Cannabis Customers in Ohio
forward to continuing to serve them with product and service excellence." With approximately $484.4 million in medical cannabis sales reported by licensed dispensaries in the state in 2023, according to the Ohio Department of Commerce, Ohio's
More news about: Ascend Wellness Holdings, Inc.
Aug 02, 2024, 14:45 ET Klutch Cannabis Announces Start of Adult Use Sales on Tuesday, August 6, 2024
through the Division's 10(b) licensing process will be brought online later in 2025. Adults 21 years of age or older wishing to purchase non-medical cannabis will need to present a valid form of identification to be admitted into a dispensary. Klutch has previously announced a planned rebranding
More news about: Klutch Cannabis
Aug 01, 2024, 07:45 ET Curaleaf Continues to Combat Food Insecurity With 4th Annual 'Feed the Block' Fundraiser
programming focused on mitigating the collateral consequences of the war on drugs through five main national causes: social justice, wellness, health, medical cannabis education, and food insecurity. From the 420x25 supplier diversity initiative to launching its nationally recognized social equity-focused brand
More news about: Curaleaf Holdings, Inc.
Aug 01, 2024, 07:00 ET Aurora Cannabis and Vectura Fertin Pharma, Inc. announce commercial collaboration
Cogent's newly-developed CBD lozenge on Aurora's Canadian medical cannabis patient platform, the potential to launch Vectura Fertin Pharma's future medical cannabis portfolio, the Company's ability to support advancements in medical cannabis and to provide its patients with access to new products, the
More news about: Aurora Cannabis Inc.
Jul 30, 2024, 07:00 ET Aurora Cannabis Inc. Reminds Shareholders to Vote in Advance of the Proxy Voting Deadline for its 2024 Annual General and Special Meeting of Shareholders
Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, would like to remind its shareholders of the Company's upcoming annual general and special meeting that will be held on Friday
More news about: Aurora Cannabis Inc.
Jul 29, 2024, 08:30 ET IM Cannabis Receives NASDAQ Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement
2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, today announced that on
More news about: IM Cannabis Corp.
Jul 29, 2024, 08:30 ET IM Cannabis Receives NASDAQ Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement
2024 /CNW/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, today announced that on
More news about: IM Cannabis Corp.
Jul 29, 2024, 08:00 ET Trulieve to Open Medical Cannabis Dispensary in Ocala, Florida
TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the opening of a new medical cannabis dispensary in Ocala, Florida.
More news about: Trulieve Cannabis Corp.
Jul 29, 2024, 07:00 ET Aurora Cannabis to Host First Quarter 2025 Investor Conference Call
/PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its first quarter 2025 on Wednesday,
More news about: Aurora Cannabis Inc.
Jul 25, 2024, 19:15 ET Aurora Receives Expanded Cultivation and Unique Research Licenses for German Facility
(NASDAQ: ACB) (TSX: ACB), a leading Canadian-based global medical cannabis company, has been granted two licenses by the Federal Institute for Drugs and Medical Devices (BfArM) under Germany's new Medical Cannabis Act (MedCanG). Aurora's license grants the company continued
More news about: Aurora Cannabis Inc.
Jul 22, 2024, 08:00 ET CannaMore Biotechs Announces Successful Completion of Phase 2a Clinical Trial for Cannabidiol-Based Treatment for Ulcerative Colitis
clinical trials to further evaluate the long-term efficacy and safety of IcBD-01, while also exploring more immediate non-drug markets (such as medical Cannabis and others) sales in parallel to the drug R&D aimed for an FDA approval. About CannaMore Biotechs Ltd. CannaMore Biotechs
More news about: CannaMore Biotechs
Jul 12, 2024, 07:30 ET IM Cannabis Shares Commence Trading on 6:1 Consolidated Basis
July 12, 2024 /CNW/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IM Cannabis"), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that, further to its press release dated
More news about: IM Cannabis Corp.
Jul 12, 2024, 07:30 ET IM Cannabis Shares Commence Trading on 6:1 Consolidated Basis
12, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IM Cannabis"), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that, further to its press release dated
More news about: IM Cannabis Corp.